Skip to Main Content

Paper Details

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.
Cancer Chemother Pharmacol
1
2022
Author NameAffiliation
Emile E VoestNetherlands Cancer Institute
  • 1 - 1

Datasets

Release 1.2